Archangels - Making The Future


Archangel Informal Investment is Scotland's leading Business Angel Syndicate. Originally formed in 1992 and based in Edinburgh, the syndicate now comprises around 100 investor members and is investing c. £10m per year in early stage Scottish companies, including leverage from partners the largest being the Scottish Enterprise Co-Investment Fund.


We invest equity only, with no preferential terms, and provide significant business experience and networking opportunities to our portfolio companies.  We seek to invest in companies with high growth potential and global application and are prepared to become involved at all stages from proof of concept through growth capital in a wide variety of business sectors.  To find out more about our investment criteria and our decision making process please visit the Investment section.


We are always keen to attract new investor members and welcome the opportunity to meet with potential members to discuss our approach to investment.  We are an unregulated activity in terms of the FSA and therefore rely on certification of members as either High Net Worth Individuals or Sophisticated Investors as defined by the FSMA 2000.  Unless otherwise stated, all investment opportunities are carried out under the Enterprise Investment Scheme (EIS) rules and therefore attract tax benefits.  Please visit our Investors section to find out more about membership.

Our office is based in Central Edinburgh and provides resources for reviewing all investment opportunities and monitoring the performance of portfolio companies.  We are the largest partner of the Scottish Co-Investment Fund  which provides matching equity funding of up to 50% (£1m max) on any qualifying investment if required.


There are currently around 26 companies in our portfolio covering a wide spectrum of business activities.  Visit ourPortfolio section to find out more about the companies in which we are currently invested and follow the links to the websites of those companies for further information.

Latest News

Bloxx Awarded International Patents

27 Mar 2014
Bloxx Awarded International Patents for its Dynamic Real-Time Web Page Categorisation Software

Touch Bionics sales reach £12.3 million in 2013

20 Jan 2014
20 January 2014 – Touch Bionics, a provider of world-leading prosthetic technologies, today announced that preliminary results indicate the company achieved revenue growth of 23% in 2013 to reach £12.3m in total sales.

PowerPhotonic Signs Partnership Deal in Israel

25 Oct 2013
World leader in precision laser micro-optics expands presence in new markets.

Touch Bionics executive receives high Scottish honour

07 Oct 2013
Livingston, Scotland – October 5, 2013 – Touch Bionics, a provider of world-leading prosthetic technologies, is proud to announce that the company’s Chief Technical Officer, Hugh Gill, has been inducted into the Scottish Engineering Hall of Fame, taking his place alongside engineering pioneers such as James Watt and Thomas Telford.

Bloxx Announces Secure Sockets Layer Intercept (SSLI) Software Development Kit for Security Solution Providers

28 Aug 2013
Boston, Mass., (August 27, 2013) – With an increasing level of Web traffic rapidly moving to the encrypted Hypertext Transfer Protocol Secure (HTTPS) protocol, Bloxx is now offering its Secure Sockets Layer Intercept (SSLI) Software Development Kit (SDK) for security solution providers and security application developers seeking to add SSL traffic intercept capabilities to their Web content filtering, firewall or Unified Threat Management (UTM) solutions.